vs
Side-by-side financial comparison of Cellectis S.A. (CLLS) and LANDMARK BANCORP INC (LARK). Click either name above to swap in a different company.
LANDMARK BANCORP INC is the larger business by last-quarter revenue ($18.8M vs $9.5M, roughly 2.0× Cellectis S.A.). LANDMARK BANCORP INC runs the higher net margin — 27.0% vs -265.9%, a 292.9% gap on every dollar of revenue. On growth, Cellectis S.A. posted the faster year-over-year revenue change (375.0% vs 14.0%).
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.
Landmark Bancorp Inc is a U.S.-based bank holding company operating Landmark National Bank, primarily serving communities across Kansas. It provides a full range of personal and commercial banking services including deposit accounts, residential mortgages, commercial loans, and wealth management solutions, catering to individual consumers, small businesses and local mid-sized enterprises.
CLLS vs LARK — Head-to-Head
Income Statement — Q2 FY2024 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $9.5M | $18.8M |
| Net Profit | $-25.3M | $5.1M |
| Gross Margin | — | — |
| Operating Margin | -181.1% | — |
| Net Margin | -265.9% | 27.0% |
| Revenue YoY | 375.0% | 14.0% |
| Net Profit YoY | -51.9% | 7.8% |
| EPS (diluted) | $-0.28 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $18.8M | ||
| Q4 25 | — | $18.7M | ||
| Q3 25 | — | $18.2M | ||
| Q2 25 | — | $17.3M | ||
| Q1 25 | — | $16.5M | ||
| Q4 24 | — | $15.8M | ||
| Q3 24 | — | $15.9M | ||
| Q2 24 | $9.5M | $14.7M |
| Q1 26 | — | $5.1M | ||
| Q4 25 | — | $4.7M | ||
| Q3 25 | — | $4.9M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $4.7M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | $-25.3M | $3.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 31.7% | ||
| Q3 25 | — | 33.4% | ||
| Q2 25 | — | 30.9% | ||
| Q1 25 | — | 34.7% | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | — | 30.3% | ||
| Q2 24 | -181.1% | 24.5% |
| Q1 26 | — | 27.0% | ||
| Q4 25 | — | 32.1% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 25.4% | ||
| Q1 25 | — | 28.5% | ||
| Q4 24 | — | 26.5% | ||
| Q3 24 | — | 24.8% | ||
| Q2 24 | -265.9% | 20.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | $0.66 | ||
| Q3 25 | — | $0.85 | ||
| Q2 25 | — | $0.75 | ||
| Q1 25 | — | $0.81 | ||
| Q4 24 | — | $0.47 | ||
| Q3 24 | — | $0.68 | ||
| Q2 24 | $-0.28 | $0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $149.0M | $31.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $148.6M | — |
| Total Assets | $407.1M | $1.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $31.9M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $149.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $160.6M | ||
| Q3 25 | — | $155.7M | ||
| Q2 25 | — | $148.4M | ||
| Q1 25 | — | $142.7M | ||
| Q4 24 | — | $136.2M | ||
| Q3 24 | — | $139.7M | ||
| Q2 24 | $148.6M | $128.3M |
| Q1 26 | — | $1.6B | ||
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | — | $1.6B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | $407.1M | $1.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.9M | — |
| Free Cash FlowOCF − Capex | $27.6M | — |
| FCF MarginFCF / Revenue | 290.5% | — |
| Capex IntensityCapex / Revenue | 13.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $21.6M | ||
| Q3 25 | — | $10.3M | ||
| Q2 25 | — | $439.0K | ||
| Q1 25 | — | $8.0M | ||
| Q4 24 | — | $14.2M | ||
| Q3 24 | — | $8.1M | ||
| Q2 24 | $28.9M | $4.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $21.0M | ||
| Q3 25 | — | $10.1M | ||
| Q2 25 | — | $354.0K | ||
| Q1 25 | — | $8.0M | ||
| Q4 24 | — | $11.9M | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | $27.6M | $3.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 112.5% | ||
| Q3 25 | — | 55.4% | ||
| Q2 25 | — | 2.0% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | 75.6% | ||
| Q3 24 | — | 49.3% | ||
| Q2 24 | 290.5% | 25.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | 13.2% | 4.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.56× | ||
| Q3 25 | — | 2.09× | ||
| Q2 25 | — | 0.10× | ||
| Q1 25 | — | 1.71× | ||
| Q4 24 | — | 4.34× | ||
| Q3 24 | — | 2.06× | ||
| Q2 24 | — | 1.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
